Kindly MD, Inc. — Director's Dealing 2025

Sep 24, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Kindly MD, Inc. (NAKA)
CIK: 0001946573
Period of Report: 2025-09-22

Reporting Person: Creighton Andrew John (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-09-22	Common Stock	A	601503	—	Acquired	3726474	Direct

Footnotes

F1: This reflects restricted stock units ("RSUs") that shall time-vest over a four (4) year period, with no vesting during the first twelve (12) months following August 15, 2025 (the "Cliff Period"), and thereafter twenty-five percent (25%) of the RSUs shall vest upon completion of the Cliff Period, with the remaining seventy-five percent (75%) of the RSUs vesting in equal quarterly installments over the subsequent thirty six (36) months, subject to the reporting person's continued service to the issuer through each applicable vesting date.